What is TG Therapeutics's cash ratio?

TG Therapeutics (TGTX) reported cash ratio of 2.4× in Q1 2026.

How has TG Therapeutics's cash ratio changed year-over-year?

TG Therapeutics's cash ratio increased by 186.5% year-over-year, from 0.8× to 2.4×.

What is the long-term trend for TG Therapeutics's cash ratio?

Over 5 years (2020 to 2025), TG Therapeutics's cash ratio has grown at a -39.4% compound annual growth rate (CAGR), from 6.3× to 0.5×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

TG Therapeutics TGTX Cash ratio

Cash ratio at other companies

BiogenBIIB

1.1×+0.6×

BridgeBio PharmaBBIO

1.1×-2.5×

Spyre Therapeutics, Inc.SYRE

1.1×+0.5×

Krystal Biotech, Inc.KRYS

4.7×+0.8×

Arrowhead ResearchARWR

0.6×-0.2×

Roivant SciencesROIV

5×+4.4×

Other financials

Income statement

See full

Revenue$204.9M+69.6%

Gross profit$171.4M+62.8%

Operating income$34.8M+304%

Net income$19.8M+291%

EPS (diluted)$0.12+300%

Balance sheet

See full

Cash & equivalents$442.2M+235%

Total debt$753.6M+197%

Total equity$583.1M+146%

Total assets$1.5B+133%

Cash flow

See full

Operating cash flow-$17.9M+37.7%

CapEx$51.0K+104%

Free cash flow-$17.9M+37.6%

Valuation

See full

Market cap$8.15B-14.3%

Enterprise value$8.46B-11.1%

P/E17.6×-225×

P/S11.6×-13.0×

Profitability

See full

Gross margin83.1%-4.4pp

Operating margin21.3%+5.9pp

Net margin66%+55.8pp

FCF margin-6,328.4%+4,773pp

Returns & leverage

See full

Return on equity112.6%+92.9pp

Debt / equity1.3×+0.2×

Current ratio5.8×+1.8×

Where this comes from

Calculated from TG Therapeutics’s reported figures.

cash and equivalents/total current liabilities=2.4×

Based on the most recent quarter.

The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TG Therapeutics's cash ratio?: TG Therapeutics (TGTX) reported cash ratio of 2.4× in Q1 2026.
How has TG Therapeutics's cash ratio changed year-over-year?: TG Therapeutics's cash ratio increased by 186.5% year-over-year, from 0.8× to 2.4×.
What is the long-term trend for TG Therapeutics's cash ratio?: Over 5 years (2020 to 2025), TG Therapeutics's cash ratio has grown at a -39.4% compound annual growth rate (CAGR), from 6.3× to 0.5×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.